🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-arm, open, phase II clinical trial aimed at evaluati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06706895
Treatments Being Tested
This study is a single-center, single-arm, open-label, phase II clinical tr...
Status
Recruiting
Location
Tongji Hospital
Start Date
2023-11-28
Trial ID
NCT06199895
Treatments Being Tested
This study is a randomized, open-label, controlled, multicenter Phase II tr...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer center
Start Date
2026-06
Trial ID
NCT07581795
The purpose of this study is to investigate the efficacy and safety of neoa...
Status
Recruiting
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2025-04-20
Trial ID
NCT06356688
Treatments Being Tested
This trial is a multi-center, randomized, open, parallel-group and positive...
Status
Recruiting
Location
Jiangsu Province Hospital
Start Date
2025-02-05
Trial ID
NCT06752811
The purpose of this study is to demonstrate bioequivalence of IG-001 versus...
Status
Completed
Location
Sorrento investigational site
Start Date
2014-03
Trial ID
NCT02064829
Treatments Being Tested
This multicenter, randomized, open, parallel positive control study compare...
Status
Recruiting
Location
Jiangsu province Hospital
Start Date
2023-09-25
Trial ID
NCT06143553
Paclitaxel polymeric micelles 300 mg/m², IV infusion over ≥3 hours, Day 1; ...
Status
Recruiting
Location
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2026-07-01
Trial ID
NCT07662746
Treatments Being Tested
This is a prospective, single-arm, single-center, phaseⅡtrial to evaluate t...
Status
Unknown
Location
Jiangsu Cancer Institute & Hospital
Start Date
2023-03-15
Trial ID
NCT05782426
Treatments Being Tested